Constellation Pharmaceuticals to Host Conference Call to Discuss First Quarter 2020 Results
28 Avril 2020 - 3:00PM
Constellation Pharmaceuticals, Inc., a clinical-stage
biopharmaceutical company using its expertise in epigenetics to
discover and develop novel therapeutics, will host a conference
call at 8:00 AM EDT on May 6, 2020, to discuss its first quarter
2020 results and progress in its clinical programs. The event will
be webcast live and can be accessed on the Investor Relations
section of Constellation’s website at
http://ir.constellationpharma.com/events-and-presentations/events.
To participate in the live question-and-answer session, please dial
(877) 473-2077 (domestic) or (661) 378-9662 (international) and
refer to conference ID 4372778.
About Constellation Pharmaceuticals
Constellation Pharmaceuticals is a clinical-stage
biopharmaceutical company developing novel therapeutics that
selectively modulate gene expression to address serious unmet
medical needs in patients with cancer. The Company has a deep
understanding of how epigenetic and chromatin modifications in
cancer cells and in the tumor and immune microenvironment play a
fundamental role in driving disease progression and drug
resistance. Constellation is driving development of the BET
inhibitor CPI-0610 for the treatment of myelofibrosis as well as
the EZH2 inhibitors CPI-1205 and CPI-0209 for the treatment of
metastatic castration-resistant prostate cancer and other cancers.
The Company is also applying its broad research and development
capabilities to explore other novel targets that directly and
indirectly impact gene expression to fuel a sustainable pipeline of
innovative small-molecule product candidates.
Contacts
Kia Khaleghpour, Ph.D.Vice President, Investor Relations
and CommunicationsConstellation Pharmaceuticals+1
617-844-6859kia.khaleghpour@constellationpharma.com
Ronald Aldridge Senior Director, Investor RelationsConstellation
Pharmaceuticals+1
617-714-0539ron.aldridge@constellationpharma.com
Lauren ArnoldMedia RelationsMacDougall Biomedical
Communications+1 781-235-3060larnold@macbiocom.com
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Constellation Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur